Quantum Biopharma (QNTM) Receivables - Other (2019 - 2025)

Quantum Biopharma's Receivables - Other history runs 6 years deep, the most recent figure standing at $231053.0 for Q4 2025.

• In Q4 2025, Receivables - Other fell 38.33% year-over-year to $231053.0; the TTM figure through Dec 2025 stood at $231053.0 (down 38.33% YoY), while the FY2025 annual figure was $231053.0, down 38.33% from the prior year.
• Receivables - Other came in at $231053.0 for Q4 2025 at Quantum Biopharma, down from $2.9 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $7.4 million in Q1 2023 to a low of $228764.0 in Q4 2023.
• A 4-year average of $3.4 million and a median of $3.0 million in 2025 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other surged 151.45% in 2023 and tumbled 59.07% in 2025, its largest moves.
• Quantum Biopharma's Receivables - Other stood at $374377.0 in 2022, then sank by 38.89% to $228764.0 in 2023, then jumped by 63.78% to $374678.0 in 2024, then sank by 38.33% to $231053.0 in 2025.
• According to Business Quant data, Receivables - Other over the past three periods registered $231053.0, $2.9 million, and $3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison